Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Selective JAK-2 inhibitor BMS-911543 enters clinic as myelofibrosis therapy

Dec. 17, 2010

Preclinical study in MM shows activity of GNE-652 and synergism with GDC-0941

Dec. 17, 2010

ACY-1215/bortezomib combination shows promise in models of multiple myeloma

Dec. 17, 2010

Preliminary phase I data presented on TAK-285 in advanced cancer

Dec. 17, 2010

Proton MRS can measure potential biomarkers for delirium in brain

Dec. 16, 2010

MLN-0905 has antitumor effects in murine model of diffuse large B-cell lymphoma

Dec. 16, 2010

Phase I data support safety of BIIB-021 plus trastuzumab in HER2-positive breast cancer

Dec. 16, 2010

ONO-013105 synergizes with rituximab in models of MCL and advances in phase I trial

Dec. 16, 2010

HG-829 reverses resistance to antineoplastic agents in vitro and in vivo

Dec. 16, 2010

CCX-721 has antitumor effects in murine model of multiple myeloma

Dec. 15, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...